Phase I/IIa Study of the Novel Combination of Bendamustine With Irinotecan Followed by Etoposide/Carboplatin in Chemonaive Patients With Extensive Stage Small Cell Lung Cancer
Phase of Trial: Phase I/II
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Bendamustine (Primary) ; Irinotecan (Primary) ; Carboplatin; Etoposide
- Indications Small cell lung cancer
- Focus Adverse reactions
- 07 Jul 2016 Status changed from active, no longer recruiting to completed.
- 01 Feb 2016 Planned End Date changed from 1 Dec 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.
- 16 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.